Walgreens Boots Alliance (WBA) Lowers FY EPS Guidance to $4-$4.05 from $4.45-$4.65
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
CVS Health (CVS) Trades Lower in Sympathy Following Results from Walgreens (WBA)
June 27, 2023 7:11 AM EDTCVS Health (NYSE: CVS) Trades Lower in Sympathy Following Results from Walgreens (NASDAQ: WBA)
Walgreens revises full-year adjusted EPS guidance to $4.00 to $4.05 from $4.45 to $4.65, to reflect consumer and category conditions, lower COVID-19 contribution, and a more cautious macroeconomic forward viewWBA -7%CVS -2%
Walgreens Boots Alliance (WBA) Misses Q3 EPS by 8c, Cuts FY Guidance
June 27, 2023 7:01 AM EDT(Updated - June 27, 2023 7:03 AM EDT)
Walgreens Boots Alliance (NASDAQ: WBA) reported Q3 EPS of $1.00, $0.08 worse than the analyst estimate of $1.08. Revenue for the quarter came in at $35.4 billion versus the consensus estimate of $34.24 billion.
GUIDANCE:
Walgreens Boots Alliance sees... More
